About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,786 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,786 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2921-2940 of 4,786 trials

TerminatedMilademetan in Advanced/Metastatic Solid TumorsPhase 2, multicenter, single-arm, open-label basket study designed to evaluate the safety and efficacy of milademetan in patients with advanced or metastatic solid tumors…NCT05012397·Palo Alto, California and 13 others TerminatedTissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the PancreasThe goal of this clinical research study is to learn if gemcitabine can enter pancreas cancer cells, to measure the amount of it that may enter the cells, and for biomarker…NCT01276613·Houston, Texas CompletedAdjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00059826·Gainesville, Florida and 13 others

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

CompletedDose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) proﬁles of RMC-4630 and cobimetinib in adult participants with…NCT03989115·Scottsdale, Arizona and 23 others

CompletedDevelopment of Assist Tool for Breast Examination Using the Principle of Ultrasonic SensorThe accuracy of breast examinations and ultrasonography performed clinically to detect breast mass varies greatly depending on the physician\'s skill level, and the accuracy…NCT06255808·Seoul, Seoul

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

Active not recruitingA Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursThis clinical trial is evaluating a drug called HMBD-001 (an anti-HER3 monoclonal antibody) in participants with advanced HER3 positive solid tumours.NCT05057013·London and 3 others

RecruitingSBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic CancerThis is a Phase II, prospective, single-arm exploratory clinical trial designed to evaluate the efficacy and safety of stereotactic body radiotherapy followed by ipilimumab N01…NCT07683221·Jinan, Shandong

TerminatedLapatinib and Capecitabine for Second Line Treatment of Pancreas CancerPatients are being asked to participate in this study who have locally advanced or metastatic pancreatic cancer (cancer of the pancreas that has spread to another part of the…NCT00881621·Washington D.C., District of Columbia

UnknownSurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic LesionsThe SurePathTM has been approved by the FDA since 1997.NCT03606148·Seoul

Not yet recruitingFeasibility of the Loop Brush EUS-FNA for Characterization of Pancreatic Cysts: Pilot Clinical InvestigationThis investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in humans.NCT07814326·Umeå

UnknownA Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic CancerInduction chemotherapy will be administered every 2 weeks for 6 cycles (about 3 months).NCT00149578·Taipei and 1 other

CompletedA Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerThe purpose of this study is to determine the safety and tolerability of three intratumoral injections of VCN-01 combined with Abraxane®/gemcitabine, and to determine the…NCT02045589·L'Hospitalet de Llobregat, Barcelona and 2 others

CompletedSorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryRATIONALE: Sorafenib and erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00837876·Paducah, Kentucky and 5 others

UnknownCombined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal PancreatectomyEligible patients will be centrally randomized to either Arm A (resection of the splenic vein after isolation from the pancreatic parenchyma) or Arm B (co-resection of the vein…NCT02871804·Wakayama

TerminatedThe Natural History of Solid Organ Cancer Stem Cells (SOCSC)Background: * Researchers are trying to learn what causes certain types of cancer to spread to other organs in the body (metastasis).NCT00923052·Bethesda, Maryland

CompletedA Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk GroupsPanFAM-1 is a clinical study for early detection of pancreatic cancer in high-risk groups.NCT03693378·Stanford, California and 20 others

UnknownA Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic CancerThis is a single arm, open-label study of CPI-613 in combination with gemcitabine and nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer never…NCT03435289·Morristown, New Jersey and 1 other

RecruitingSurufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic CancerThis study is designed to explore the efficacy and safety of surufatinib combined with camrelizumab and AS (nab-paclitaxel and S-1) as first-line treatment compared with AG…NCT05218889·Beijing

Active not recruitingSafety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsThis is a Phase 1a, open label, single dose, extended study of safety and biokinetics of RAD301 in healthy human volunteers and individuals with PDAC or Other Solid TumorsNCT05799274·Princeton, New Jersey and 1 other

PreviousPage 147 of 240Next